Sugi Predict

Sugi Predict / Compounds / SCHEMBL2901666

SCHEMBL2901666

SCHEMBL2901666

O=P(c1ccccc1)(c1ccccc1)c1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.47
▸ ERBB2 P04626 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ AHR P35869 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ HPGD P15428 5/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ THRB P10828 1/20 0.47
▸ CYP3A4 P08684 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ POLB P06746 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30892130 1.00 CYP1A2 (0.47) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2384413 0.96 CYP1A2 (0.47) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL29662001 0.96 CYP1A2 (0.47) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL11991091 0.94 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL9927201 0.94 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL11962348 0.92 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL9927193 0.91 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL9927199 0.91 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12918597 0.91 ESR1 (0.45) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL9927191 0.90 CYP1A2 (0.46) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4947000-A ANALYSIS FOR LIPID PEROXIDE BY FLUORESCING UPON REACTING TOSOH CORPORATION (JP) 1990-08-07 — — US claimed
EP-3055891-B1 SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT NOVALED GMBH (DE) 2024-10-30 — — EP disclosed
EP-3281238-B1 SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT NOVALED GMBH (DE) 2024-04-24 — — EP disclosed
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 — — US disclosed
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 — — US disclosed
US-20220190296-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-16 — — US disclosed
US-20220173331-A1 LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-02 — — US disclosed
US-11309495-B2 Semiconducting material comprising a phosphine oxide matrix and metal salt NOVALED GMBH (DE) 2022-04-19 — — US disclosed
CN-111093607-A Cosmetic composition for protecting skin against active oxygen species, ultraviolet rays or fine dusts comprising red gallol 济州大学校产学协力团 2020-05-01 — — CN disclosed
US-10297757-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-21 — — US disclosed
US-20090247634-A1 Methods for identifying modulators of eoxin formation CLAESSON HANS-ERIK 2009-10-01 — — US disclosed
US-20090247634-A1 Methods for identifying modulators of eoxin formation CLAESSON HANS-ERIK 2009-10-01 — — US disclosed
US-20090247634-A1 Methods for identifying modulators of eoxin formation CLAESSON HANS-ERIK 2009-10-01 — — US disclosed
EP-2035573-A1 METHODS FOR IDENTIFYING MODULATORS OF EOXIN FORMATION Biolipox AB (SE) 2009-03-18 — — EP disclosed
US-20080238307-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT FUJIFILM CORPORATION (JP) 2008-10-02 — — US disclosed
US-20080238307-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT FUJIFILM CORPORATION (JP) 2008-10-02 — — US disclosed
US-20080241518-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT UDC IRELAND LIMITED (IE) 2008-10-02 — — US disclosed
US-20080241518-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT UDC IRELAND LIMITED (IE) 2008-10-02 — — US disclosed
WO-2008001079-A1 METHODS FOR IDENTIFYING MODULATORS OF EOXIN FORMATION BIOLIPOX AB (SE) 2008-01-03 — — WO disclosed
JP-2002122593-A METHOD FOR ANALYZING PEROXIDATION OF CELL NOGUCHI NORIKO 2002-04-26 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247634-A1 Methods for identifying modulators of eoxin formation LTA4H, LTC4S, LTB4R2 CYP1A2 1118/4885ERBB2 3884/4885FYN 1155/4885
US-20230284524-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME EML4, SLC1A2, EMD CYP1A2 1632/4885ERBB2 3210/4885FYN 4473/4885
US-11309495-B2 Semiconducting material comprising a phosphine oxide matrix and metal salt C1S, C5, SLC26A3 CYP1A2 3206/4885ERBB2 950/4885FYN 3087/4885
US-10297757-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device TERT, PIEZO1, ETV6 CYP1A2 1426/4885ERBB2 4177/4885FYN 3104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.